This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Propagated protein misfolding of SOD1 in ALS: Exemplar for neurodegeneration. Investments > €500k Canada Motor neurone diseases 2016
REGULATION OF THE STRESS GRANULE PROTEOME AND TRANSCRIPTOME BY TDP-43 IN ALS: BIOMARKERS AND THERAPEUTIC TARGETS Investments > €500k Canada Motor neurone diseases 2016
Discovery of Therapeutic Targets for FUS- and TDP43-Dependent Forms of ALS Investments > €500k Canada Motor neurone diseases 2016
Preclinical and clinical studies with withanolides: Therapeutic effects, molecular signatures and biomarkers Investments > €500k Canada Motor neurone diseases 2016
Novel MRI biomarkers for monitoring disease progression in ALS Investments > €500k Canada Motor neurone diseases 2016
Selective knockdown of misfolded SOD1 as a therapy for amyotrophic lateral sclerosis Investments > €500k Canada Motor neurone diseases 2016
Non Invasive Identification of Aβ Plaques in Human Retina for the Diagnosis of Alzheimer’s Disease Investments > €500k Canada Alzheimer’s disease & other dementias 2016
Canadian Centre for Aging and Brain Health Innovation Investments > €500k Canada Alzheimer’s disease & other dementias 2016
TRIAD : From pictures to numbers: adding throughput and readout to imaging in AD diagnostics Investments > €500k Belgium Alzheimer’s disease & other dementias 2016
TherALS-1 : Characterisation of novel small molecule regenerative compounds for the treatment of amyotrophic lateral sclerosis Investments > €500k Belgium Motor neurone diseases 2016
